MGP
Metis Global Partners’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.08M | Sell |
65,916
-7,142
| -10% | -$767K | 0.18% | 92 |
|
2025
Q1 | $7.37M | Buy |
73,058
+11,106
| +18% | +$1.12M | 0.21% | 86 |
|
2024
Q4 | $5.53M | Buy |
61,952
+2,726
| +5% | +$243K | 0.17% | 103 |
|
2024
Q3 | $4.96M | Buy |
59,226
+2,248
| +4% | +$188K | 0.15% | 116 |
|
2024
Q2 | $4.39M | Buy |
56,978
+498
| +0.9% | +$38.4K | 0.15% | 113 |
|
2024
Q1 | $3.87M | Sell |
56,480
-466
| -0.8% | -$31.9K | 0.14% | 126 |
|
2023
Q4 | $3.29M | Sell |
56,946
-4,344
| -7% | -$251K | 0.13% | 137 |
|
2023
Q3 | $3.24M | Buy |
61,290
+5,875
| +11% | +$310K | 0.16% | 125 |
|
2023
Q2 | $3M | Buy |
55,415
+202
| +0.4% | +$10.9K | 0.16% | 123 |
|
2023
Q1 | $2.76M | Buy |
55,213
+14,914
| +37% | +$746K | 0.18% | 118 |
|
2022
Q4 | $1.86M | Buy |
40,299
+14,514
| +56% | +$672K | 0.17% | 135 |
|
2022
Q3 | $1M | Buy |
25,785
+1,884
| +8% | +$73.1K | 0.16% | 150 |
|
2022
Q2 | $891K | Buy |
23,901
+1,380
| +6% | +$51.4K | 0.14% | 170 |
|
2022
Q1 | $998K | Buy |
22,521
+10,103
| +81% | +$448K | 0.12% | 156 |
|
2021
Q4 | $528K | Buy |
+12,418
| New | +$528K | 0.15% | 152 |
|